Endurance Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.18M | Sell |
15,284
-2
| -0% | -$160 | 0.16% | 88 |
|
|
2023
Q1 | $1.27M | Hold |
15,286
| – | – | 0.18% | 83 |
|
|
2022
Q4 | $1.31M | Sell |
15,286
-200
| -1% | -$15.8K | 0.2% | 81 |
|
|
2022
Q3 | $955K | Sell |
15,486
-200
| -1% | -$12.6K | 0.16% | 90 |
|
|
2022
Q2 | $970K | Sell |
15,686
-2,899
| -16% | -$179K | 0.15% | 95 |
|
|
2022
Q1 | $1.1M | Sell |
18,585
-433
| -2% | -$27.7K | 0.14% | 94 |
|
|
2021
Q4 | $1.38M | Sell |
19,018
-911
| -5% | -$62.7K | 0.15% | 101 |
|
|
2021
Q3 | $1.39M | Sell |
19,929
-86
| -0.4% | -$6.04K | 0.15% | 104 |
|
|
2021
Q2 | $1.38M | Hold |
20,015
| – | – | 0.15% | 104 |
|
|
2021
Q1 | $1.29M | Sell |
20,015
-7,728
| -28% | -$498K | 0.15% | 103 |
|
|
2020
Q4 | $1.62M | Sell |
27,743
-650
| -2% | -$39.2K | 0.2% | 85 |
|
|
2020
Q3 | $1.79M | Buy |
28,393
+8,150
| +40% | +$565K | 0.26% | 78 |
|
|
2020
Q2 | $1.56M | Sell |
20,243
-425
| -2% | -$32.6K | 0.26% | 78 |
|
|
2020
Q1 | $1.54M | Buy |
20,668
+25
| +0.1% | +$1.73K | 0.3% | 71 |
|
|
2019
Q4 | $1.34M | Hold |
20,643
| – | – | 0.21% | 83 |
|
|
2019
Q3 | $1.31M | Sell |
20,643
-34
| -0.2% | -$2.22K | 0.22% | 81 |
|
|
2019
Q2 | $1.4M | Sell |
20,677
-200
| -1% | -$13.2K | 0.22% | 80 |
|
|
2019
Q1 | $1.36M | Sell |
20,877
-200
| -0.9% | -$13.3K | 0.22% | 83 |
|
|
2018
Q4 | $1.32M | Sell |
21,077
-1,210
| -5% | -$84.6K | 0.25% | 82 |
|
|
2018
Q3 | $1.72M | Hold |
22,287
| – | – | 0.27% | 79 |
|
|
2018
Q2 | $1.58M | Sell |
22,287
-1,000
| -4% | -$70.6K | 0.26% | 79 |
|
|
2018
Q1 | $1.76M | Sell |
23,287
-723
| -3% | -$57.5K | 0.3% | 78 |
|
|
2017
Q4 | $1.72M | Sell |
24,010
-2,150
| -8% | -$163K | 0.28% | 79 |
|
|
2017
Q3 | $2.12M | Sell |
26,160
-6,155
| -19% | -$471K | 0.35% | 69 |
|
|
2017
Q2 | $2.29M | Sell |
32,315
-200
| -0.6% | -$13.3K | 0.39% | 60 |
|
|
2017
Q1 | $2.21M | Sell |
32,515
-900
| -3% | -$63.3K | 0.38% | 61 |
|
|
2016
Q4 | $2.39M | Sell |
33,415
-224
| -0.7% | -$16.6K | 0.43% | 60 |
|
|
2016
Q3 | $2.54M | Sell |
33,639
-5,100
| -13% | -$414K | 0.45% | 59 |
|
|
2016
Q2 | $3.23M | Sell |
38,739
-650
| -2% | -$57.7K | 0.61% | 49 |
|
|
2016
Q1 | $3.62K | Sell |
39,389
-650
| -2% | -$58.6K | 0.51% | 47 |
|
|
2015
Q4 | $4.05M | Sell |
40,039
-3,149
| -7% | -$328K | 0.77% | 47 |
|
|
2015
Q3 | $4.3M | Sell |
43,188
-71
| -0.2% | -$7.88K | 0.76% | 38 |
|
|
2015
Q2 | $5.07M | Sell |
43,259
-1,992
| -4% | -$218K | 0.85% | 35 |
|
|
2015
Q1 | $4.44M | Sell |
45,251
-2,775
| -6% | -$282K | 0.78% | 39 |
|
|
2014
Q4 | $4.53M | Sell |
48,026
-1,829
| -4% | -$189K | 0.81% | 38 |
|
|
2014
Q3 | $5.31M | Sell |
49,855
-350
| -0.7% | -$34.3K | 0.99% | 33 |
|
|
2014
Q2 | $4.16M | Buy |
50,205
+4,875
| +11% | +$379K | 0.69% | 43 |
|
|
2014
Q1 | $3.21M | Sell |
45,330
-11,450
| -20% | -$898K | 0.62% | 49 |
|
|
2013
Q4 | $4.26M | Sell |
56,780
-1,375
| -2% | -$95.7K | 0.84% | 38 |
|
|
2013
Q3 | $3.66M | Sell |
58,155
-1,975
| -3% | -$118K | 0.77% | 41 |
|
|
2013
Q2 | $3.08M | Buy |
+60,130
| New | +$3.13M | 0.69% | 46 |
|
Other funds holding GILD
Endurance Wealth Management's GILD Position: Q2 2023 in Review
Endurance Wealth Management reduced its Gilead Sciences (GILD) stake by 0.01% in Q2 2023, selling an estimated $160 and leaving 15,284 shares worth $1.18M. The position accounts for 0.16% of the portfolio, ranked #88.
Endurance Wealth Management first reported a position in GILD in Q2 2013 and has held it in 41 quarters since. The position peaked at $5.31M in Q3 2014. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.
- Endurance Wealth Management held 15,284 shares of Gilead Sciences worth $1.18M as of Q2 2023.
- Endurance Wealth Management sold 2 Gilead Sciences shares in Q2 2023, an estimated $160.
- Gilead Sciences made up 0.16% of Endurance Wealth Management's portfolio in Q2 2023, its #88 holding.
- Endurance Wealth Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 41 quarters since.
- Endurance Wealth Management's Gilead Sciences position peaked at $5.31M in Q3 2014.
- 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.
Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.